These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7700948

  • 1. Behavioral effects of the reversible dopamine antagonist flupenthixol are not potentiated by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in the preweanling rat.
    McDougall SA, Bolanos CA.
    Pharmacol Biochem Behav; 1995 Jan; 50(1):127-31. PubMed ID: 7700948
    [Abstract] [Full Text] [Related]

  • 2. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors.
    Mestlin M, McDougall SA.
    Pharmacol Biochem Behav; 1993 Aug; 45(4):797-802. PubMed ID: 8105488
    [Abstract] [Full Text] [Related]

  • 3. Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats.
    Der-Ghazarian T, Gutierrez A, Varela FA, Herbert MS, Amodeo LR, Charntikov S, Crawford CA, McDougall SA.
    Neuroscience; 2012 Dec 13; 226():427-40. PubMed ID: 23000622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2(High) receptors.
    McDougall SA, Valentine JM, Gonzalez AE, Humphrey DE, Widarma CB, Crawford CA.
    Psychopharmacology (Berl); 2014 Apr 13; 231(8):1637-47. PubMed ID: 24287603
    [Abstract] [Full Text] [Related]

  • 7. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
    Meller E, Bordi F, Bohmaker K.
    Life Sci; 1989 Apr 13; 44(15):1019-26. PubMed ID: 2564615
    [Abstract] [Full Text] [Related]

  • 8. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
    McDougall SA, Crawford CA, Nonneman AJ.
    Psychopharmacology (Berl); 1992 Apr 13; 106(4):502-10. PubMed ID: 1349753
    [Abstract] [Full Text] [Related]

  • 9. Behavioral effects of selective and nonselective dopamine agonists on young rats after irreversible antagonism of D1 and/or D2 receptors.
    McDougall SA, Crawford CA, Nonneman AJ.
    Psychopharmacology (Berl); 1993 Apr 13; 111(2):225-32. PubMed ID: 7870957
    [Abstract] [Full Text] [Related]

  • 10. Effects of EEDQ on the synthesis and metabolism of dopamine in preweanling and adult rats.
    Crawford CA, McDougall SA, Bardo MT.
    Neuropharmacology; 1994 Dec 13; 33(12):1559-65. PubMed ID: 7760979
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF, Waszczak BL.
    Brain Res; 1993 Jun 04; 613(1):32-42. PubMed ID: 8102308
    [Abstract] [Full Text] [Related]

  • 12. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW, Creese I.
    Life Sci; 1983 May 09; 32(19):2247-55. PubMed ID: 6133202
    [Abstract] [Full Text] [Related]

  • 13. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF, Waszczak BL.
    Mol Pharmacol; 1989 Jan 09; 35(1):125-31. PubMed ID: 2563304
    [Abstract] [Full Text] [Related]

  • 14. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL, Ong A, McGonigle P.
    Synapse; 1995 Feb 09; 19(2):134-43. PubMed ID: 7725242
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.
    Undie AS, Berki AC, Beardsley K.
    Neuropharmacology; 2000 Feb 09; 39(1):75-87. PubMed ID: 10665821
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.